JP2006298804A - Aerosol composition - Google Patents
Aerosol composition Download PDFInfo
- Publication number
- JP2006298804A JP2006298804A JP2005121026A JP2005121026A JP2006298804A JP 2006298804 A JP2006298804 A JP 2006298804A JP 2005121026 A JP2005121026 A JP 2005121026A JP 2005121026 A JP2005121026 A JP 2005121026A JP 2006298804 A JP2006298804 A JP 2006298804A
- Authority
- JP
- Japan
- Prior art keywords
- component
- aerosol composition
- antiperspirant
- present
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 239000000443 aerosol Substances 0.000 title claims abstract description 29
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 12
- 239000000194 fatty acid Substances 0.000 claims abstract description 12
- 229930195729 fatty acid Natural products 0.000 claims abstract description 12
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 12
- -1 chlorohydroxy aluminum Chemical compound 0.000 claims abstract description 11
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 229920005862 polyol Polymers 0.000 claims abstract description 8
- 150000003077 polyols Chemical class 0.000 claims abstract description 8
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910052726 zirconium Inorganic materials 0.000 claims abstract description 4
- HSEYYGFJBLWFGD-UHFFFAOYSA-N 4-methylsulfanyl-2-[(2-methylsulfanylpyridine-3-carbonyl)amino]butanoic acid Chemical compound CSCCC(C(O)=O)NC(=O)C1=CC=CN=C1SC HSEYYGFJBLWFGD-UHFFFAOYSA-N 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 29
- 210000002374 sebum Anatomy 0.000 abstract description 4
- 230000028327 secretion Effects 0.000 abstract description 4
- LCQXXBOSCBRNNT-UHFFFAOYSA-K ammonium aluminium sulfate Chemical compound [NH4+].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O LCQXXBOSCBRNNT-UHFFFAOYSA-K 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000001166 anti-perspirative effect Effects 0.000 description 31
- 239000003213 antiperspirant Substances 0.000 description 31
- 239000000843 powder Substances 0.000 description 14
- 239000003380 propellant Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000002781 deodorant agent Substances 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 210000004243 sweat Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000035985 Body Odor Diseases 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 206010040904 Skin odour abnormal Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- 239000003915 liquefied petroleum gas Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- CRSOQBOWXPBRES-UHFFFAOYSA-N neopentane Chemical compound CC(C)(C)C CRSOQBOWXPBRES-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 229940092782 bentonite Drugs 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940068886 polyethylene glycol 300 Drugs 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N sec-butylidene Natural products CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、エアゾール組成物に関し、更に詳しくは、制汗効果の発現が早く、かつ、その持続性にも優れたエアゾール組成物に関する。 The present invention relates to an aerosol composition, and more particularly to an aerosol composition that exhibits an antiperspirant effect quickly and is excellent in its sustainability.
従来より、汗による肌のべたつき、不快感などの低減のために制汗デオドラント剤が用いられている。日本における高温多湿の気候からさっぱりとした使用感が好まれ、エアゾール型の制汗剤がその清涼感から広く用いられている。 Conventionally, an antiperspirant deodorant has been used to reduce the stickiness and discomfort of the skin due to sweat. A refreshing feeling of use is preferred due to the hot and humid climate in Japan, and aerosol type antiperspirants are widely used due to its refreshing feeling.
このようなエアゾール型制汗剤組成物には、通常、液化した揮発性噴射剤と、その中に分散している有効成分、また、これらの成分を肌上に付着させるための展着剤として油分が配合されている。その制汗機構は、収斂性アルミニウム化合物を用いることにより、その収斂作用で発汗を抑制している。 Such an aerosol type antiperspirant composition usually has a liquefied volatile propellant, an active ingredient dispersed therein, and a spreading agent for adhering these ingredients onto the skin. Contains oil. The antiperspirant mechanism uses a convergent aluminum compound to suppress perspiration due to its astringent action.
一方、従来の制汗剤組成物等としては、例えば、粉体状の水溶性制汗有効成分、粉体、シリコーン、多価アルコール類を含有する原液および噴射剤とから成ることを特徴とする非水系粉末エアゾール型制汗剤組成物(例えば、本願出願人による特許文献1参照)や、皮膚化粧料制汗成分と、メントール及びメントール誘導体と、多価アルコールを含有してなることを特徴とする皮膚化粧料(例えば、本願出願人による特許文献2参照)、更に、A成分:水溶性のヒドロキシカルボン酸及び/又は水溶性のアルミニウム塩と、B成分:常温で液体の脂肪酸とを含有するデオドラント組成物(例えば、本願出願人による特許文献3参照)が知られている。 On the other hand, as a conventional antiperspirant composition, for example, it consists of a powdery water-soluble antiperspirant active ingredient, powder, silicone, a stock solution containing polyhydric alcohols, and a propellant. Non-aqueous powder aerosol type antiperspirant composition (for example, refer to Patent Document 1 by the applicant of the present application), skin cosmetic antiperspirant component, menthol and menthol derivative, and polyhydric alcohol Skin cosmetics (see, for example, Patent Document 2 by the applicant of the present application), further, component A: a water-soluble hydroxycarboxylic acid and / or a water-soluble aluminum salt, and component B: a fatty acid that is liquid at room temperature. Deodorant compositions (see, for example, Patent Document 3 by the present applicant) are known.
しかしながら、上記特許文献1及び2記載の非水系粉末エアゾール型制汗剤組成物や皮膚化粧料は、優れた制汗・防臭効果を有するものであるが、制汗・防臭効果の持続性が若干不十分である点に課題があり、また、上記特許文献3記載のデオドラント組成物は、今までにない制汗効果を有するものであるが、制汗効果の即効性が若干十分ではない点に課題があり、更に、制汗効果の即効性と持続性に優れたエアゾール型の制汗剤の出現が望まれているのが現状である。
本発明は、上記従来技術の課題及び現状等に鑑み、これを解消しようとするものであり、製剤を塗布した直後から制汗効果を発現させ、かつ、その効果を持続させることにより、皮膚常在菌によって分解される汗や皮脂などの分泌物量を低減させ不快な体臭を抑制するエアゾール組成物を提供することを目的とする。 The present invention is to solve this problem in view of the above-mentioned problems of the prior art and the current situation, and develops an antiperspirant effect immediately after the preparation is applied and maintains the effect to maintain the normal skin condition. An object of the present invention is to provide an aerosol composition that reduces the amount of secretions such as sweat and sebum decomposed by bacteria and suppresses unpleasant body odor.
本発明者は、上記従来の課題等を解決するために、鋭意検討した結果、特定の制汗成分と、特定の脂肪酸、製剤を塗布した直後から制汗効果を発現させる特定成分とを少なくとも含有することにより、上記目的のエアゾール組成物が得られることを見出し、本発明を完成するに至ったのである。
すなわち、本発明のエアゾール組成物は、下記(A)成分、(B)成分及び(C)成分を含有することを特徴とする。
(A)成分:水溶性のアルミニウム塩
(B)成分:常温で液体の脂肪酸
(C)成分:ポリオール
As a result of intensive studies to solve the above-described conventional problems, the present inventor contains at least a specific antiperspirant component, a specific fatty acid, and a specific component that exhibits an antiperspirant effect immediately after the preparation is applied. As a result, the inventors have found that the above-mentioned aerosol composition can be obtained, and have completed the present invention.
That is, the aerosol composition of the present invention is characterized by containing the following component (A), component (B) and component (C).
(A) Component: Water-soluble aluminum salt (B) Component: Fatty acid liquid at normal temperature (C) Component: Polyol
本発明によれば、製剤を塗布した直後から制汗効果を発現させ、かつ、その効果を持続させることにより、皮膚常在菌によって分解される汗や皮脂などの分泌物量を低減させ不快な体臭を抑制するエアゾール組成物が提供される。 According to the present invention, an antiperspirant effect is exhibited immediately after application of the preparation, and the effect is maintained, thereby reducing the amount of secretions such as sweat and sebum decomposed by the skin resident bacteria, and unpleasant body odor. An aerosol composition is provided that inhibits
以下に、本発明の実施形態を詳しく説明する。
本発明のエアゾール組成物は、水溶性のアルミニウム塩〔(A)成分〕と、常温で液体の脂肪酸〔(B)成分〕と、ポリオール〔(C)成分〕とを含有することを特徴とするものである。
Hereinafter, embodiments of the present invention will be described in detail.
The aerosol composition of the present invention comprises a water-soluble aluminum salt [component (A)], a fatty acid [component (B)] that is liquid at room temperature, and a polyol [component (C)]. Is.
本発明に用いる(A)成分は、水溶性のアルミニウム塩であることが必要である。
用いることができる水溶性のアルミニウム塩としては、例えば、塩化アルミニウム、硫酸アルミニウム、クロルヒドロキシアルミニウム、ブロモヒドロキシアルミニウム、クロルヒドロキシアルミニウム/ジルコニウム、硫酸アルミニウムアンモニウムなどが挙げられる。これらの中でも、特に、クロルヒドロキシアルミニウム、クロルヒドロキシアルミニウム/ジルコニウム、硫酸アルミニウムアンモニウムが刺激性が少ないという点から望ましい。
本発明において上記(A)成分は、1種または2種以上を組み合わせて用いることができる。
The component (A) used in the present invention needs to be a water-soluble aluminum salt.
Examples of water-soluble aluminum salts that can be used include aluminum chloride, aluminum sulfate, chlorohydroxyaluminum, bromohydroxyaluminum, chlorohydroxyaluminum / zirconium, and aluminum ammonium sulfate. Among these, chlorohydroxyaluminum, chlorohydroxyaluminum / zirconium, and aluminum ammonium sulfate are particularly desirable from the viewpoint of low irritation.
In the present invention, the component (A) can be used alone or in combination of two or more.
これらの(A)成分のうち、水溶性のアルミニウム塩を単独で又は併用で用いる場合、その含有量は、噴射剤を除くエアゾール組成物(原液組成物)全量に対して、5〜40質量%(以下、単に「%」という)とすることが好ましく、更に好ましくは、5〜30%とすることが望ましい。
この(A)成分の含有量が、5%未満であると、制汗効果を十分に発揮することができず、一方、40%を超えると、べたつき等の使用感触の低下、皮膚刺激等の懸念がある。
Among these (A) components, when a water-soluble aluminum salt is used alone or in combination, the content thereof is 5 to 40% by mass with respect to the total amount of the aerosol composition (stock solution composition) excluding the propellant. (Hereinafter, simply referred to as “%”) is preferable, and 5 to 30% is more preferable.
If the content of the component (A) is less than 5%, the antiperspirant effect cannot be sufficiently exerted. On the other hand, if it exceeds 40%, the feeling of use such as stickiness is reduced, skin irritation, etc. There are concerns.
本発明で用いる(B)成分は、常温で(25℃、以下同様)で液体の脂肪酸であることが必要である。
用いることができる常温で液体の脂肪酸としては、例えば、イソステアリン酸、オレイン酸、リノール酸、リノレン酸などが挙げられる。これらの中でも、ニオイの点などからイソステアリン酸が好ましい。
本発明において上記(B)成分は、1種または2種以上を組み合わせて用いることができる。
The component (B) used in the present invention needs to be a fatty acid that is liquid at room temperature (25 ° C., the same applies hereinafter).
Examples of fatty acids that are liquid at room temperature include isostearic acid, oleic acid, linoleic acid, and linolenic acid. Among these, isostearic acid is preferable from the viewpoint of odor.
In the present invention, the component (B) can be used alone or in combination of two or more.
これらの(B)成分である常温で液体の脂肪酸の含有量は、噴射剤を除くエアゾール組成物(原液組成物)全量に対して、1〜10%とすることが好ましく、更に好ましくは、1〜7%とすることが望ましい。
この(B)成分の含有量が、1%未満であると、本発明の効果を発揮することができず、一方、10%を超えると、脂肪酸の皮膚への刺激が懸念される。
The content of these fatty acids that are liquid at room temperature as the component (B) is preferably 1 to 10%, more preferably 1%, based on the total amount of the aerosol composition (stock solution composition) excluding the propellant. It is desirable to set it to -7%.
When the content of the component (B) is less than 1%, the effect of the present invention cannot be exhibited. On the other hand, when the content exceeds 10%, there is a concern about fatty acid irritation to the skin.
本発明で用いる(C)成分は、ポリオールであることが必要である。
用いることができるポリオールとしては、例えば、プロピレングリコール、ジプロピレングリコール、エチレングリコール、ジエチレングリコール、1,3−ブチレングリコール、イソプレングリコール、ヘキシレングリコール等のグリコール類、グリセリン、ソルビトール等の糖アルコール、ポリエチレングリコール300、ポリエチレングリコール400、ポリエチレングリコール1500、ポリエチレングリコール4000、ポリエチレングリコール6000等の重量平均分子量が200〜10,000のポリエチレングリコールなどが挙げられる。これらの中でも、安定性の点から、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、ポリエチレングリコール300等がより望ましい。
本発明において上記(C)成分は、1種または2種以上を組み合わせて用いることができる。
The component (C) used in the present invention needs to be a polyol.
Examples of the polyol that can be used include glycols such as propylene glycol, dipropylene glycol, ethylene glycol, diethylene glycol, 1,3-butylene glycol, isoprene glycol, and hexylene glycol, sugar alcohols such as glycerin and sorbitol, and polyethylene glycol. Examples include polyethylene glycol having a weight average molecular weight of 200 to 10,000, such as 300, polyethylene glycol 400, polyethylene glycol 1500, polyethylene glycol 4000, and polyethylene glycol 6000. Among these, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol 300, and the like are more preferable from the viewpoint of stability.
In the present invention, the component (C) can be used alone or in combination of two or more.
これらの(C)成分であるポリオールの含有量は、噴射剤を除くエアゾール組成物(原液組成物)全量に対して、0.01〜20%が好ましく、更に好ましくは、1〜5%とすることが望ましい。
この(C)成分の含有量が0.01%未満であると、制汗効果の発現を十分に早くすることが困難となる場合があり、一方、20%を越えると、べたつき等の使用感の低下となる。
The content of the polyol as the component (C) is preferably 0.01 to 20%, more preferably 1 to 5% with respect to the total amount of the aerosol composition (stock solution composition) excluding the propellant. It is desirable.
When the content of the component (C) is less than 0.01%, it may be difficult to make the antiperspirant effect sufficiently early. On the other hand, when the content exceeds 20%, the feeling of use such as stickiness may occur. Decrease.
本発明において、上記(A)成分、(B)成分及び(C)成分の他に、エアゾール成分となる噴射剤としては、例えば、プロパン、イソブタン、ノルマルブタン、イソペンタン、ネオペンタン等の炭化水素系ガス(LPG)、及び、ジメチルエーテル(DME)等の液化ガスなどを用いることができる。これらに加えて、炭酸ガス、窒素ガスを用いてもよい。上記の噴射剤は、それぞれ単独で、または2種類以上を混合して使用することができる。
これらの噴射剤の含有量は、エアゾール容器の構造、エアゾル組成物の用途、使用部位などに異なるものであるが、原液組成物:噴射剤の配合比率としては、含有比(質量基準)で、0.1:99.9〜30:70とすることが好ましく、更に好ましくは、1:99〜30:70、特に好ましくは、1:99〜15:85とすることが望ましい。
In the present invention, in addition to the component (A), the component (B) and the component (C), examples of the propellant that becomes an aerosol component include hydrocarbon gases such as propane, isobutane, normal butane, isopentane, and neopentane. (LPG) and liquefied gas such as dimethyl ether (DME) can be used. In addition to these, carbon dioxide gas and nitrogen gas may be used. Said propellant can be used individually or in mixture of 2 or more types, respectively.
The content of these propellants varies depending on the structure of the aerosol container, the use of the aerosol composition, the use site, etc., but the blend ratio of the stock solution composition: the propellant is the content ratio (mass basis), The ratio is preferably 0.1: 99.9 to 30:70, more preferably 1:99 to 30:70, and particularly preferably 1:99 to 15:85.
また、本発明のエアゾール組成物には、上記(A)成分、(B)成分及び(C)成分の他に、本発明を損なわない範囲で、エアゾール組成物に常用されている各成分(任意成分)を適宜含有することができる。
本発明に用いることができる任意成分としては、例えば、水溶性ヒドロキシカルボン酸、油脂類、ワックス類、シリコーン類、酸化防止剤、有機粉体、無機粉体、界面活性剤、香料、防腐剤、紫外線吸収剤、キレート剤、保湿剤、増粘剤、清涼剤、殺菌剤、抗炎症剤、アミノ酸、植物エキス、包接化合物等が挙げられる。
In addition to the components (A), (B) and (C) described above, the aerosol composition of the present invention includes components (arbitrary) commonly used in aerosol compositions within a range that does not impair the present invention. Component) can be contained as appropriate.
Examples of optional components that can be used in the present invention include water-soluble hydroxycarboxylic acids, oils and fats, waxes, silicones, antioxidants, organic powders, inorganic powders, surfactants, fragrances, preservatives, Examples include ultraviolet absorbers, chelating agents, humectants, thickeners, cooling agents, bactericides, anti-inflammatory agents, amino acids, plant extracts, and inclusion compounds.
具体的には、クエン酸、リンゴ酸、酒石酸、ナイロン末、ポリエチレン末、無水ケイ酸、シリコーンパウダー、セルロース粉体、タルク、カオリン、マイカ等の使用性向上粉体、多孔質マグネシアシリカ粉体、合成層状ピロケイ酸マグネシウム粉体、アルギン酸カルシウム粉体(2次凝集物)、アパタイト粉体等の消臭粉体、メチルパラベン、エチルパラベン、安息香酸ナトリウム、エタノール類等の防腐剤、ベントナイト、グリチルレチン酸ステアリル等の皮膚保護剤、グリセリン、ヒアルロン酸、尿素等の保湿剤、アロエエキス、ユーカリエキス、クワエキス、シラカバエキス等の植物抽出エキス、ヒドロキシプロピルセルロース、ヒドロキシメチルセルロース等の粘度調整剤、ウロカニン酸、パラアミノ安息香酸、パラメトキシケイ皮酸イソプロピル、ヒドロキシメトキシベンゾフェノン等の紫外線吸収剤、トコフェノール等の抗酸化剤、顔料、香料等が挙げられる。 Specifically, citric acid, malic acid, tartaric acid, nylon powder, polyethylene powder, silicic anhydride, silicone powder, cellulose powder, talc, kaolin, mica, and other usability improving powders, porous magnesia silica powder, Synthetic layered magnesium pyrosilicate powder, calcium alginate powder (secondary aggregate), deodorant powder such as apatite powder, preservatives such as methylparaben, ethylparaben, sodium benzoate, ethanol, bentonite, stearyl glycyrrhetinate Skin protectants such as glycerin, hyaluronic acid, urea and other moisturizers, aloe extract, eucalyptus extract, mulberry extract, birch extract and other plant extract extracts, hydroxypropylcellulose, hydroxymethylcellulose and other viscosity modifiers, urocanic acid, paraaminobenzoic acid Acid, paramethoxy cinnamon Isopropyl, ultraviolet absorbers such as hydroxy methoxy benzophenone, antioxidants such as tocopherol, pigments, perfumes and the like.
このように構成される本発明のエアゾール組成物では、(A)成分である水溶性のアルミニウム塩で肌を収斂させ、制汗効果を発揮させ、(B)成分の水に難溶な常温で液体の脂肪酸の含有により、その脂肪酸が徐々に溶解することで、肌上で徐々に溶けてそのpH(酸性)を長期間維持でき、しかも、(C)成分のポリオールの含有により、(A)成分である水溶性のアルミニウム塩の皮膚上での水溶性を向上させるため、即効性がでることとなるため、制汗効果の発現が早く、かつ、その持続性にも優れたものとなる。従って、本発明では、製剤を塗布した直後から制汗効果を発現させ、かつ、その効果を持続させることにより、皮膚常在菌によって分解される汗や皮脂などの分泌物量を低減させ不快な体臭を抑制するエアゾール組成物が得られることとなる。 In the aerosol composition of this invention comprised in this way, the water-soluble aluminum salt which is (A) component is made to converge skin, the antiperspirant effect is exhibited, and (B) at the normal temperature which is hardly soluble in the water of component By containing the liquid fatty acid, the fatty acid gradually dissolves, so that it gradually dissolves on the skin and can maintain its pH (acidity) for a long time. In addition, by containing the polyol (C), (A) Since the water-soluble aluminum salt, which is a component, improves the water-solubility on the skin, an immediate effect is obtained, so that the antiperspirant effect is quickly developed and the sustainability is excellent. Therefore, in the present invention, an antiperspirant effect is exhibited immediately after application of the preparation, and the effect is maintained, thereby reducing the amount of secretions such as sweat and sebum decomposed by the skin resident bacteria, and unpleasant body odor. An aerosol composition that suppresses the above will be obtained.
次に、実施例及び比較例により本発明を更に詳細に説明するが、下記実施例等に限定されるものではない。 EXAMPLES Next, although an Example and a comparative example demonstrate this invention further in detail, it is not limited to the following Example etc.
〔実施例1〜9及び比較例1〜3〕
下記表1及び表2に示す組成により原液組成物を調製し、噴射剤として液化石油ガスを用いてエアゾール組成物(製剤)を調製した。
得られた各エアゾール組成物を用いて、下記試験方法により制汗効果の発現性の早さとその持続性について評価した。
これらの試験結果を下記表1及び表2に示す。
[Examples 1 to 9 and Comparative Examples 1 to 3]
A stock solution composition was prepared according to the composition shown in Table 1 and Table 2 below, and an aerosol composition (formulation) was prepared using liquefied petroleum gas as a propellant.
Using each of the obtained aerosol compositions, the rapidity and persistence of the antiperspirant effect was evaluated by the following test method.
These test results are shown in Tables 1 and 2 below.
<制汗効果の評価方法>
皮膚水分蒸散量(TEWL)測定装置(Tewameter TM210 CK electronic社製)を用いて測定を行った。
前腕内側部に2cm×2cmの枠を作り、皮膚から10cm離した位置から2秒間、上記枠の中に製剤をスプレー塗布した。25〜40歳の健常男性パネラー10名を高温条件(室温28℃以上)下で一定の発汗を示すまでおき、下記式で示されるそのときの無塗布部位の平均インピーダンス値に対する塗布部位の平均インピーダンス値で制汗効果を求め、10名の制汗効果(%)の平均を求め、その平均値を下記評価基準に従って評価した。
制汗効果(%)={100−(塗布部位の平均インピーダンス値/無塗布部位の平均インピーダンス値)}×100
<評価基準>
◎:60%以上
○:30%以上60%未満
△:10%以上30%未満
×:10%未満
<Evaluation method of antiperspirant effect>
The measurement was performed using a skin moisture transpiration (TEWL) measuring device (manufactured by Tewmeter TM210 CK electronic).
A 2 cm × 2 cm frame was formed on the inner side of the forearm, and the preparation was sprayed into the frame for 2 seconds from a position 10 cm away from the skin. 10 healthy male panelists aged 25 to 40 years old until they show constant sweating under high temperature conditions (room temperature 28 ° C. or higher), and the average impedance of the application site with respect to the average impedance value of the non-application site at that time shown by the following formula The antiperspirant effect was determined by the value, the average of the antiperspirant effect (%) of 10 persons was determined, and the average value was evaluated according to the following evaluation criteria.
Antiperspirant effect (%) = {100− (average impedance value of application site / average impedance value of non-application site)} × 100
<Evaluation criteria>
◎: 60% or more ○: 30% or more and less than 60% △: 10% or more and less than 30% ×: less than 10%
上記表1及び表2の結果から明らかなように、本発明の範囲となる実施例1〜9は、本発明の範囲外となる比較例1〜3に較べて、制汗効果の発現が早く、かつ、その持続性にも優れたものとなることが判明した。
これに対して、本願発明の(A)成分、(B)成分及び(C)成分の何れか一つ以上含まないエアゾール組成物では、本発明の効果を発揮できないことが判明した。
As is apparent from the results of Tables 1 and 2, Examples 1-9, which are within the scope of the present invention, exhibit an antiperspirant effect faster than Comparative Examples 1-3, which are outside the scope of the present invention. In addition, it has been found that the durability is excellent.
In contrast, it has been found that an aerosol composition that does not include any one or more of the component (A), the component (B), and the component (C) of the present invention cannot exhibit the effects of the present invention.
Claims (2)
(A)成分:水溶性のアルミニウム塩
(B)成分:常温で液体の脂肪酸
(C)成分:ポリオール An aerosol composition comprising the following component (A), component (B) and component (C):
(A) Component: Water-soluble aluminum salt (B) Component: Fatty acid liquid at normal temperature (C) Component: Polyol
The aerosol composition according to claim 1, wherein the component (A) is at least one selected from chlorohydroxyaluminum, chlorohydroxyaluminum / zirconium, and aluminum ammonium sulfate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005121026A JP2006298804A (en) | 2005-04-19 | 2005-04-19 | Aerosol composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005121026A JP2006298804A (en) | 2005-04-19 | 2005-04-19 | Aerosol composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006298804A true JP2006298804A (en) | 2006-11-02 |
Family
ID=37467300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005121026A Pending JP2006298804A (en) | 2005-04-19 | 2005-04-19 | Aerosol composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006298804A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526311A (en) * | 2012-02-21 | 2012-07-04 | 简福川 | Chinese medicinal preparation for treating sweaty feet |
JP2015500252A (en) * | 2011-12-12 | 2015-01-05 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Anhydrous antiperspirant composition |
-
2005
- 2005-04-19 JP JP2005121026A patent/JP2006298804A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015500252A (en) * | 2011-12-12 | 2015-01-05 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Anhydrous antiperspirant composition |
CN102526311A (en) * | 2012-02-21 | 2012-07-04 | 简福川 | Chinese medicinal preparation for treating sweaty feet |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0616015B1 (en) | anhydrous based composition, anhydrous aerosol composition and process for manufacturing an anhydrous antiperspirant aerosol composition | |
JP2003012511A (en) | Aerosol composition | |
MX2007006144A (en) | Underarm cosmetic method and compositions. | |
EP3876900B1 (en) | Antiperspirant compositions | |
AU734796B2 (en) | Antiperspirant or deodorant compositions | |
WO1997048373A1 (en) | Cosmetic composition containing an antiperspirant or deodorant and a moisturising cream | |
JP4381231B2 (en) | Body odor deodorant cosmetic | |
JP6357018B2 (en) | Deodorant composition for foot | |
WO2019206764A1 (en) | An antiperspirant composition | |
ES2812540T3 (en) | Use as a deodorizing agent of a salified salicylic acid derivative, alone or in a mixture | |
JP2006298804A (en) | Aerosol composition | |
CN109069374A (en) | Antiperspirant composition | |
JP2018521099A (en) | Cosmetic formulations that reduce sweat | |
JP6900121B2 (en) | Antiperspirant composition and antiperspirant | |
JP6683522B2 (en) | Cooling external skin preparation | |
JP4293883B2 (en) | Deodorant composition | |
JPH10182348A (en) | Cosmetic | |
JP4694960B2 (en) | Aerosol antiperspirant composition | |
JP3027838B2 (en) | Eyazole composition | |
JP3905512B2 (en) | Aerosol composition | |
JP2018521097A (en) | Cosmetic formulations that reduce sweat | |
JP7296837B2 (en) | antiperspirant composition | |
JP2001226258A (en) | Powder aerosol composition | |
WO2022032358A1 (en) | Antiperspirant aerosol formulation, manufacturing and packaging method, use of the antiperspirant formulation, and corresponding antiperspirant product | |
JP2007153850A (en) | Antiperspiration deodorant composition |